Tuesday, October 13, 2026

Nikola Already 5% Up, Almost Five Hours Before The NASDAQ Open

Nikola Already 5% Up, Almost Five Hours Before The NASDAQ Open

(VIANEWS) - The NASDAQ opens in less than five hours and Nikola's pre-market value is already 5.04% up.

Nikola's last close was $1.19, 86.73% below its 52-week high of $8.97.

The last session, NASDAQ ended with Nikola (NKLA) dropping 15% to $1.19. NASDAQ slid 0.68% to $13,689.57, following the last session's downward trend on what was a somewhat bearish trend exchanging session.

About Nikola

Nikola Corporation operates as a technology innovator and integrator that develops energy and transportation solutions. It operates through two business units, Truck and Energy. The Truck business unit develops and commercializes battery electric vehicles (BEV) and hydrogen fuel cell electric vehicles (FCEV) to the trucking sector. The Energy business unit develops and constructs a network of hydrogen fueling stations; and offers BEV charging solutions for its FCEV and BEV customers, as well as other third-party customers. The company also assembles, integrates, and commissions its vehicles in collaboration with its business partners and suppliers. Nikola Corporation founded in 2015 and is headquartered in Phoenix, Arizona.

Earnings Per Share

As for profitability, Nikola has a trailing twelve months EPS of $-2.2.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -137.05%.

Volume

Today's last reported volume for Nikola is 234060381 which is 455.47% above its average volume of 42137100.

Revenue Growth

Year-on-year quarterly revenue growth grew by 489.1%, now sitting on 60.05M for the twelve trailing months.

Sales Growth

Nikola's sales growth is negative 16.8% for the current quarter and 37.9% for the next.

Moving Average

Nikola's value is way above its 50-day moving average of $0.86 and way below its 200-day moving average of $2.42.

More news about Nikola (NKLA).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,372 source documents archived
Query this data → isubstrate.com